OLANZAPINE TEVA ® 15 MG

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

OLANZAPINE 15 MG

Prieinama:

SALOMON,LEVIN & ELSTEIN LTD

ATC kodas:

N05AH03

Vaisto forma:

FILM COATED TABLETS

Vartojimo būdas:

PER OS

Pagaminta:

TEVA OPERATIONS POLAND SP.ZO.O

Farmakoterapinė grupė:

OLANZAPINE

Terapinės indikacijos:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Leidimo data:

2011-04-01